Skip to main content
logo
Mankind Pharma Limited (NSE:MANKIND)
India flag India · Delayed Price · Currency is INR
2,472.00
-103.90 (-4.03%)
Jul 31, 2026, 3:30 PM IST

Mankind Pharma Revenue

Mankind Pharma had revenue of 40.31B INR in the quarter ending June 30, 2026, with 12.89% growth. This brings the company's revenue in the last twelve months to 147.38B, up 14.16% year-over-year. In the fiscal year ending March 31, 2026, Mankind Pharma had annual revenue of 142.78B with 16.96% growth.

Revenue (ttm)
147.38B
Revenue Growth
+14.16%
P/S Ratio
6.92
Revenue / Employee
7.21M
Employees
20,451
Market Cap
1.02T

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026142.78B20.70B16.96%
Mar 31, 2025122.07B19.47B18.98%
Mar 31, 2024102.60B15.11B17.27%
Mar 31, 202387.49B9.68B12.44%
Mar 31, 202277.82B15.67B25.22%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma336.53B
Cipla280.68B
Zydus Lifesciences271.48B
Glenmark Pharmaceuticals177.76B
Alkem Laboratories147.12B
Divi's Laboratories105.60B
Ipca Laboratories96.47B
Emcure Pharmaceuticals92.04B
Revenue Rankings

Mankind Pharma News

More News